Literature DB >> 32062792

Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart.

Mitchel Tate1,2, Gavin C Higgins2,3, Miles J De Blasio1, Runa Lindblom2,3, Darnel Prakoso1, Minh Deo1, Helen Kiriazis4, Min Park5, Carlos D Baeza-Garza5, Stuart T Caldwell6, Richard C Hartley6, Thomas Krieg5, Michael P Murphy5,7, Melinda T Coughlan2,3, Rebecca H Ritchie8,9.   

Abstract

The article "The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart".

Entities:  

Year:  2020        PMID: 32062792      PMCID: PMC7645541          DOI: 10.1007/s10557-019-06929-2

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  2 in total

Review 1.  Basic Mechanisms of Diabetic Heart Disease.

Authors:  Rebecca H Ritchie; E Dale Abel
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

2.  Methylglyoxal Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via RAGE-Induced ROS Generation: Protective Effects of Metformin.

Authors:  Matheus L Medeiros; Akila L Oliveira; Mariana G de Oliveira; Fabíola Z Mónica; Edson Antunes
Journal:  J Inflamm Res       Date:  2021-12-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.